The Targeted Therapy Market Is Projected To Grow At An 8% Rate Through The Forecast Period As Per The Business Research Company's Targeted Therapy Global Market Report 2023

Loading...
Loading...

LONDON, May 01, 2023 (GLOBE NEWSWIRE) -- The Business Research Company's research on the targeted therapy market forecasts that the market is expected to expand from $97.3 billion in 2022 to $106.7 billion in 2023, at a compound annual growth rate (CAGR) of more than 9%.The targeted therapy market share is then projected to grow to $148.3 billion in 2027 at a CAGR of more than 8%. North America was the largest region in the market in 2022.

The growing incidence of cancer is expected to drive the expansion of the targeted therapy market size in the coming years. According to the American Cancer Society's 2021 report, 1.8 million new cases of cancer were diagnosed in 2020. The National Cancer Institute, a US government organization that is part of the National Institutes of Health, reported a 43% increase in new cancer cases registered in September 2020 compared to 2019.

Learn More In-Depth On The Targeted Therapy Industry

https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report

Several prominent players operating in the targeted therapy market include Sanofi, Merck & Co., Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Amgen Inc., GlaxoSmithKline plc, and AstraZeneca.

New product development is an emerging trend, with major targeted therapy companies focused on creating innovative technological solutions to reinforce their market position. For example, in March 2022, Novartis AG, a Switzerland-based multinational pharmaceutical corporation, introduced Pluvicto, the first targeted radioligand therapy (RLT) approved by the US Food and Drug Administration (FDA) for eligible patients with mCRPC. Pluvicto combines a therapeutic radioisotope with a targeted chemical, or a radioactive particle, to achieve its therapeutic effect.

Loading...
Loading...

Get A Free Sample Of The Global Targeted Therapy Market Report

https://www.thebusinessresearchcompany.com/sample.aspx?id=9129&type=smp

The global targeted therapy market is segmented as:

1) By Type: Small Molecule Medicines, Monoclonal Antibodies

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Application: Breast Cancer, Colorectal Cancer, Leukemia, Lung Cancer, Lymphoma, Renal Cancer, Other Applications

The Business Research Company research's report further provides detailed information on the market segmentation, also covering the market's various sub-segments. The report also includes a competitive landscape analysis of the targeted therapy sector, which highlights the leading players in the industry and their strategies for growth.

Targeted Therapy Global Market Report 2023 by The Business Research Company provides insights on the targeted therapy market size, targeted therapy market segments, targeted therapy market trends, drivers and restraints, major competitors' market positioning, revenues and market shares.

The Business Research Company has published over 3,000+ industry reports, covering more than 2,500+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Learn More About The Business Research Company

The Business Research Company is a market intelligence firm pioneering in company, market, and consumer research. With offices all around the world, TBRC has specialist consultants in a variety of fields, including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model – World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.


The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsManagementAnalyst RatingsPress ReleasesAnalyst Recommendations
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...